Sirio Pharma Co., Ltd. (SHE:300791)

Market Cap	7.47B
Revenue (ttm)	4.26B
Net Income (ttm)	331.71M
Shares Out	305.65M
EPS (ttm)	1.09
PE Ratio	22.45
Forward PE	20.43
Dividend	0.50 (2.04%)
Ex-Dividend Date	May 27, 2025

Volume	3,640,051
Average Volume	5,040,949
Open	25.21
Previous Close	24.37
Day's Range	23.81 - 25.21
52-Week Range	16.32 - 28.19
Beta	0.43
RSI	50.36
Earnings Date	Aug 26, 2025

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 2,776
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300791

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.